OpenEvidence Alternatives for Doctors in Australia and New Zealand (2026)

Several AI evidence tools are open to doctors in Australia and New Zealand. OpenEvidence says "OpenEvidence Australia is now available". Its "Learn more" link opens a sign-in page. Tools with a published Australian or New Zealand offer include Heidi Evidence, ClinicalKey AI, Vera Health, MedLuma (for Australian GPs) and AttendMe AI. Your health service library may also give you UpToDate or DynaMed.

AttendMe AI publishes this page, and AttendMe is one of the tools listed. Each third-party fact below links to its source, checked on 21 October 2026. Prices and access change, so check the vendor page before you decide.

What it is. An AI evidence answer engine for clinicians.

Access in Australia and New Zealand. OpenEvidence's site says "OpenEvidence Australia is now available". Its "Learn more" link opens a sign-in page. Its iOS app is listed on the New Zealand App Store, but not on the Australian App Store. Its terms ask for a National Provider Identifier "or, as applicable, other professional licensing number" at registration. The terms exclude only the EU, the UK, the EEA and US-embargoed countries. Access in the EU and UK ended in April 2026.

Price. Free for verified US clinicians, says its App Store listing. The American Academy of Ophthalmology says ophthalmologists in Australia and New Zealand can use it at no cost (as of 22 June 2026). We found no other published price for Australia or New Zealand.

Local content. None stated.

Sources: OpenEvidence terms of use, OpenEvidence on the New Zealand App Store, American Academy of Ophthalmology, TTA report on the UK and EU exit.

What it is. An evidence answer tool from Heidi Health, a company founded in Melbourne. It works on its own or with the Heidi AI scribe.

Access. Heidi has Australian and New Zealand Evidence pages with free sign-up.

Price. Free for individual clinicians. Heidi's Evidence page says "Unlimited Free Clinical Answers". Its pricing page lists Evidence on the Free plan as "Limited usage" under a fair use policy. Paid team plans add team evidence guidelines and an organisation-wide evidence library.

Local content. Heidi says Evidence is built in partnership with HealthPathways, EMGuidance, MIMS, Vidal, NICE and BMJ Group, amongst others.

Sources: Heidi Evidence launch, Heidi Evidence (Australia), Heidi Evidence (New Zealand), Heidi pricing.

What it is. Elsevier's clinical decision support tool. It combines Elsevier and non-Elsevier content with conversational search powered by generative AI.

Access. Elsevier sells individual subscriptions in Australia and New Zealand.

Price. US$39 a month or US$349 a year on Elsevier's store page. The page shows "$"; its price data is in US dollars.

Local content. No Australian or New Zealand sources are listed. Listed sources include ACC, ACEP, CHEST and ESMO guidelines, NEJM, The Lancet and JAMA Network journals.

Sources: ClinicalKey AI, ClinicalKey AI subscriptions.

What it is. A generative AI layer over UpToDate content, from Wolters Kluwer.

Access. UpToDate Expert AI has its own app on the Australian App Store. The app needs an UpToDate subscription with Expert AI turned on. The UpToDate app listing says Expert AI is in personal trainee and Pro Plus subscriptions in the US, and "through select Enterprise Edition accounts". We could not confirm that an individual Australian or New Zealand subscription includes Expert AI. Ask your health service library.

Price. We found no published Australian or New Zealand price.

Local content. None stated.

Sources: UpToDate on the Australian App Store, UpToDate Expert AI on the Australian App Store.

What it is. AI clinical search for Australian general practice, from Medcast.

Access. Built for Australian GPs. We found no New Zealand offer.

Price. A free Medcast Explorer tier includes 50 MedLuma searches. The page does not say if the 50 renew each month. Medcast Plus is $45 a month with 200 searches a month. The page does not state the currency.

Local content. MedLuma says it draws on Australian guidelines such as the RACGP Red Book and the National Asthma Handbook, AJGP research and the Medicare Benefits Schedule.

Sources: MedLuma, MedLuma for general practitioners.

What it is. A clinical search engine over papers and guidelines.

Access. Vera names Australia among the countries where verified clinicians can use the full platform.

Price. Free for licensed clinicians and trainees.

Local content. Vera's blog names Australia's NHMRC as an example of the national guidance it aims to support. It does not list the Australian guidelines it indexes.

Sources: Vera Health, Vera on country-specific guidelines.

What it is. Clinical decision support from AttendMe Pty Ltd, an Australian company. Short answers with numbered citations from 3.7M+ journal articles and 74,000+ guideline sections, plus 150 clinical calculators, 412 clinical pathways, paper appraisal and study comparison.

Access. Built in Australia. Doctors in New Zealand and other countries can also sign up. Web, iOS and Android.

Price. A free plan with 10 chat questions and 1 Deep Research query a month. Pro is A$50 a month or A$500 a year. Enterprise is A$100 per user a month.

Local content. Answers are adapted for Australian clinical practice. AttendMe does not yet adapt answers for New Zealand guidance. On a paid plan, you or your hospital can add your own protocols, and answers label them separately from the literature.

More: AttendMe for Australian and New Zealand doctors.

eTG (Therapeutic Guidelines), the Australian Medicines Handbook and BMJ Best Practice remain core references. On 21 October 2026 we did not find an AI answer feature on their websites. DynaMed offers an AI feature, Dyna AI, in some subscriptions.

Check your licence before you paste reference content into an AI tool. For example, the RACGP John Murtagh Library's DynaMed page says users "must not use any Artificial Intelligence (AI) tools or machine learning/training technologies with any material in DynaMed for any purpose".

Sources: Therapeutic Guidelines, Australian Medicines Handbook, BMJ Best Practice, EBSCO on Dyna AI, RACGP John Murtagh Library, DynaMed.

Australian and New Zealand guidance gives you the checklist. The Australian Commission on Safety and Quality in Health Care's AI Clinical Use Guide asks you to understand the tool's intended use, confirm its evidence base and limits, and know when an AI tool is a medical device that must comply with TGA rules. Ahpra asks you to apply human judgement to every AI output. The Medical Council of New Zealand asks you to be satisfied that a tool is safe, suitable for the patient and clinically justified before you use it in patient care.

Then test each tool on five questions from your own practice. Check that every claim links to a source you can open. Check whether the tool uses Australian or New Zealand guidance where that matters, and whether it can answer from your hospital's own protocols.

We summarise the guidance, with links, on AI clinical decision support for Australian and New Zealand doctors.